{'fraction_non_alphanumeric': 0.021739130434782608, 'fraction_numerical': 0.018518518518518517, 'mean_word_length': 5.341836734693878, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
An Economic Analysis of Immediate Delivery and Expectant Monitoring in Women With Hypertensive Disorders of Pregnancy, Between 34 and 37 Weeks of Gestation (HYPITAT-II)

patients and a significant change in clinical management in approximately one third of the cases. In-utero MRI corrected ultrasound findings in 25% of the cases (144/570) while ultrasound corrected an iuMRI finding in just 2 cases. Overall, diagnostic accuracy was 68% for ultrasound evaluation and 93% for iuMRI. The iuMRI testing was well received by patients with 95% of participants saying they would want an iuMRI examination again if their fetus was suspected to have a brain anomaly. In addition, 80% of mothers reported that information obtained from the iuMRI examination helped them to understand their fetus’s abnormality, and 70% felt the results contributed to a better understanding of how their infant’s brain anomaly would affect its quality of life. The improved diagnostic accuracy of combined iuMRI and ultrasound evaluation compared with ultrasound examination alone, along with high patient acceptance of iuMRI, led these investigators to recommened performance of iuMRI in any fetus with a potential brain abnormality based on ultrasound examination.